Opinion
Preventing postpartum depression: Start with women at greatest risk
Women at greatest risk include those with a history of PPD, bipolar disorder, or postpartum psychosis.
Opinion
Fetal exposure to depression: How does ‘dose’ figure in?
There is a continuum of risk when it comes to the effects of depression during pregnancy.
Opinion
Postpartum depression: Moving toward improved screening with a new app
The MGH Perinatal Depression Scale (MGHPDS) is an app that screens for postpartum depression during and after pregnancy.
Opinion
Evolving practice in perinatal psychopharmacology: Lessons learned
Here are 10 clinical scenarios in which practice diverges from the best clinical evidence.
News
Perinatal depression screening is just the start
Depression screening during and after pregnancy is recommended, but does it result in more women getting treatment?
Article
The 50-year quest for better pregnancy data
In this article, our four expert columnists share their experiences trying to find and interpret critical pregnancy data, as well as how they...
News
SAGE-547 for depression: Cause for caution and optimism
Dr. Lee S. Cohen discusses SAGE-547, a novel experimental therapy for severe postpartum depression.
News
Perinatal depression screening: New recommendations and challenges
The move toward perinatal depression screening is welcome and simply commonsense, but it is concerning that there has been so little systematic...
News
Assessing longer-term effects of SSRI exposure in pregnancy
While women who take antidepressants during pregnancy may worry about the risk of malformations, they also are concerned about how fetal exposure...
